{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:14:21Z","timestamp":1787318061805,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mercury is known to be neurotoxic, but its effects on the immune system are less well known. Mast cells are involved in allergic reactions, but also in innate and acquired immunity, as well as in inflammation. Many patients with Autism Spectrum Disorders (ASD) have \"allergic\" symptoms; moreover, the prevalence of ASD in patients with mastocytosis, characterized by numerous hyperactive mast cells in most tissues, is 10-fold higher than the general population suggesting mast cell involvement. We, therefore, investigated the effect of mercuric chloride (HgCl\n                      <jats:sub>2<\/jats:sub>\n                      ) on human mast cell activation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human leukemic cultured LAD2 mast cells and normal human umbilical cord blood-derived cultured mast cells (hCBMCs) were stimulated by HgCl2 (0.1-10 \u03bcM) for either 10 min for beta-hexosaminidase release or 24 hr for measuring vascular endothelial growth factor (VEGF) and IL-6 release by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HgCl\n                      <jats:sub>2<\/jats:sub>\n                      induced a 2-fold increase in \u03b2-hexosaminidase release, and also significant VEGF release at 0.1 and 1 \u03bcM (311 \u00b1 32 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells and 443 \u00b1 143 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells, respectively) from LAD2 mast cells compared to control cells (227 \u00b1 17 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells, n = 5, p &lt; 0.05). Addition of HgCl\n                      <jats:sub>2<\/jats:sub>\n                      (0.1 \u03bcM) to the proinflammatory neuropeptide substance P (SP, 0.1 \u03bcM) had synergestic action in inducing VEGF from LAD2 mast cells. HgCl\n                      <jats:sub>2<\/jats:sub>\n                      also stimulated significant VEGF release (360 \u00b1 100 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells at 1 \u03bcM, n = 5, p &lt; 0.05) from hCBMCs compared to control cells (182 \u00b1 57 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells), and IL-6 release (466 \u00b1 57 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells at 0.1 \u03bcM) compared to untreated cells (13 \u00b1 25 pg\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells, n = 5, p &lt; 0.05). Addition of HgCl\n                      <jats:sub>2<\/jats:sub>\n                      (0.1 \u03bcM) to SP (5 \u03bcM) further increased IL-6 release.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      HgCl\n                      <jats:sub>2<\/jats:sub>\n                      stimulates VEGF and IL-6 release from human mast cells. This phenomenon could disrupt the blood-brain-barrier and permit brain inflammation. As a result, the findings of the present study provide a biological mechanism for how low levels of mercury may contribute to ASD pathogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1742-2094-7-20","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T02:14:37Z","timestamp":1268360077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Mercury induces inflammatory mediator release from human mast cells"],"prefix":"10.1186","volume":"7","author":[{"given":"Duraisamy","family":"Kempuraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrivi","family":"Manola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoharis C","family":"Theoharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"232_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuro.2009.03.007","volume":"30","author":"RK Monroe","year":"2009","unstructured":"Monroe RK, Halvorsen SW: Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption. NeuroToxicol. 2009, 30: 589-598. 10.1016\/j.neuro.2009.03.007.","journal-title":"NeuroToxicol"},{"key":"232_CR2","first-page":"383","volume":"128","author":"DA Geier","year":"2008","unstructured":"Geier DA, King PG, Sykes LK, Geier MR: A comprehensive review of mercury provoked autism. Indian J Med Res. 2008, 128: 383-411.","journal-title":"Indian J Med Res"},{"key":"232_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0749-3797(03)00113-2","volume":"25","author":"P Stehr-Green","year":"2003","unstructured":"Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D: Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003, 25: 101-106. 10.1016\/S0749-3797(03)00113-2.","journal-title":"Am J Prev Med"},{"key":"232_CR4","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1542\/peds.2006-1262","volume":"118","author":"Y D'Souza","year":"2006","unstructured":"D'Souza Y, Fombonne E, Ward BJ: No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics. 2006, 118: 1664-1675. 10.1542\/peds.2006-1262.","journal-title":"Pediatrics"},{"key":"232_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.clpt.6100407","volume":"82","author":"F DeStefano","year":"2007","unstructured":"DeStefano F: Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther. 2007, 82: 756-759. 10.1038\/sj.clpt.6100407.","journal-title":"Clin Pharmacol Ther"},{"key":"232_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2007.113159","volume":"98","author":"JP Baker","year":"2008","unstructured":"Baker JP: Mercury, vaccines, and autism: One controversy, three histories. Am J Public Health. 2008, 98: 244-253. 10.2105\/AJPH.2007.113159.","journal-title":"Am J Public Health"},{"key":"232_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archgenpsychiatry.2007.2","volume":"65","author":"E Fombonne","year":"2008","unstructured":"Fombonne E: Thimerosal disappears but autism remains. Arch Gen Psychiatry. 2008, 65: 15-16. 10.1001\/archgenpsychiatry.2007.2.","journal-title":"Arch Gen Psychiatry"},{"key":"232_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1362361307078126","volume":"11","author":"EJ Woo","year":"2007","unstructured":"Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM: Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Autism. 2007, 11: 301-310. 10.1177\/1362361307078126.","journal-title":"Autism"},{"key":"232_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2008.04.002","volume":"271","author":"HA Young","year":"2008","unstructured":"Young HA, Geier DA, Geier MR: Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008, 271: 110-118. 10.1016\/j.jns.2008.04.002.","journal-title":"J Neurol Sci"},{"key":"232_CR10","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.4049\/jimmunol.154.7.3138","volume":"154","author":"Y Jiang","year":"1995","unstructured":"Jiang Y, Moller G: In vitro effects of HgCl2 on murine lymphocytes. I. Preferable activation of CD4+ T cells in a responder strain. J Immunol. 1995, 154: 3138-3146.","journal-title":"J Immunol"},{"key":"232_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0091-6749(99)70186-7","volume":"103","author":"J Dastych","year":"1999","unstructured":"Dastych J, Walczak-Drzewiecka A, Wyczolkowska J, Metcalfe DD: Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-beta-D-hexosaminidase and secrete IL-4 and TNF-alpha. J Allergy Clin Immunol. 1999, 103: 1108-1114. 10.1016\/S0091-6749(99)70186-7.","journal-title":"J Allergy Clin Immunol"},{"key":"232_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/taap.2001.9223","volume":"174","author":"N Strenzke","year":"2001","unstructured":"Strenzke N, Grabbe J, Plath KE, Rohwer J, Wolff HH, Gibbs BF: Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils. Toxicol Appl Pharmacol. 2001, 174: 257-263. 10.1006\/taap.2001.9223.","journal-title":"Toxicol Appl Pharmacol"},{"key":"232_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1006\/bbrc.2001.4844","volume":"283","author":"Y Suzuki","year":"2001","unstructured":"Suzuki Y, Yoshimaru T, Yamashita K, Matsui T, Yamaki M, Shimizu K: Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release. Biochem Biophys Res Commun. 2001, 283: 707-714. 10.1006\/bbrc.2001.4844.","journal-title":"Biochem Biophys Res Commun"},{"key":"232_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","volume":"27","author":"AS Kirshenbaum","year":"2003","unstructured":"Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al: Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res. 2003, 27: 677-682. 10.1016\/S0145-2126(02)00343-0.","journal-title":"Leuk Res"},{"key":"232_CR15","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1182\/blood.V93.10.3338.410k05_3338_3346","volume":"93","author":"D Kempuraj","year":"1999","unstructured":"Kempuraj D, Saito H, Kaneko A, Fukagawa K, Nakayama M, Toru H, et al: Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood. 1999, 93: 3338-3346.","journal-title":"Blood"},{"key":"232_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/en.2003-0805","volume":"145","author":"D Kempuraj","year":"2004","unstructured":"Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, et al: Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology. 2004, 145: 43-48. 10.1210\/en.2003-0805.","journal-title":"Endocrinology"},{"key":"232_CR17","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1073\/pnas.0707854105","volume":"105","author":"N Puri","year":"2008","unstructured":"Puri N, Roche PA: Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci USA. 2008, 105: 2580-2585. 10.1073\/pnas.0707854105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"232_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.bjp.0706246","volume":"145","author":"D Kempuraj","year":"2005","unstructured":"Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, et al: Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005, 145: 934-944. 10.1038\/sj.bjp.0706246.","journal-title":"Br J Pharmacol"},{"key":"232_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/bjp.2008.356","volume":"155","author":"D Kempuraj","year":"2008","unstructured":"Kempuraj D, Tagen M, Iliopoulou BP, Clemons A, Vasiadi M, Boucher W, et al: Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol. 2008, 155: 1076-1084. 10.1038\/bjp.2008.356.","journal-title":"Br J Pharmacol"},{"key":"232_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/(SICI)1097-4636(19980315)39:4<560::AID-JBM9>3.0.CO;2-H","volume":"39","author":"A Schedle","year":"1998","unstructured":"Schedle A, Samorapoompichit P, Fureder W, Rausch-Fan XH, Franz A, Sperr WR, et al: Metal ion-induced toxic histamine release from human basophils and mast cells. J Biomed Mater Res. 1998, 39: 560-567. 10.1002\/(SICI)1097-4636(19980315)39:4<560::AID-JBM9>3.0.CO;2-H.","journal-title":"J Biomed Mater Res"},{"key":"232_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2567.2008.03023.x","volume":"127","author":"Z Wu","year":"2009","unstructured":"Wu Z, Pearson A, Oliveira D: Characterization of cis-regulatory elements conferring mercury-induced interleukin-4 gene expression in rat mast cells: a role for signal transducer and activator of transcription 6 and TATA box binding sites. Immunology. 2009, 127: 530-538. 10.1111\/j.1365-2567.2008.03023.x.","journal-title":"Immunology"},{"key":"232_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","volume":"27","author":"R Paus","year":"2006","unstructured":"Paus R, Theoharides TC, Arck PC: Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol. 2006, 27: 32-39. 10.1016\/j.it.2005.10.002.","journal-title":"Trends Immunol"},{"key":"232_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","volume":"23","author":"SJ Galli","year":"2005","unstructured":"Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005, 23: 749-786. 10.1146\/annurev.immunol.21.120601.141025.","journal-title":"Annu Rev Immunol"},{"key":"232_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1196\/annals.1366.025","volume":"1088","author":"TC Theoharides","year":"2006","unstructured":"Theoharides TC, Kalogeromitros D: The critical role of mast cell in allergy and inflammation. Ann NY Acad Sci. 2006, 1088: 78-99. 10.1196\/annals.1366.025.","journal-title":"Ann NY Acad Sci"},{"key":"232_CR25","doi-asserted-by":"crossref","first-page":"C138","DOI":"10.1152\/ajpcell.1994.267.1.C138","volume":"267","author":"J Janiszewski","year":"1994","unstructured":"Janiszewski J, Bienenstock J, Blennerhassett MG: Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol. 1994, 267: C138-C145.","journal-title":"Am J Physiol"},{"key":"232_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1113\/jphysiol.1982.sp014080","volume":"323","author":"R Carraway","year":"1982","unstructured":"Carraway R, Cochrane DE, Lansman JB, Leeman SE, Paterson BM, Welch HJ: Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol. 1982, 323: 403-414.","journal-title":"J Physiol"},{"key":"232_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.188.6.1135","volume":"188","author":"J Boesiger","year":"1998","unstructured":"Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, et al: Mast cells can secrete vascular permeability factor\/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc\u03b5 receptor I expression. J Exp Med. 1998, 188: 1135-1145. 10.1084\/jem.188.6.1135.","journal-title":"J Exp Med"},{"key":"232_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1091\/mbc.9.4.875","volume":"9","author":"A Grutzkau","year":"1998","unstructured":"Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, et al: Synthesis, storage and release of vascular endothelial growth factor\/vascular permeability factor (VEGF\/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell. 1998, 9: 875-884.","journal-title":"Mol Biol Cell"},{"key":"232_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10016-001-0299-x","volume":"17","author":"RJ Laham","year":"2003","unstructured":"Laham RJ, Li J, Tofukuji M, Post M, Simons M, Sellke FW: Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins. Ann Vasc Surg. 2003, 17: 245-252. 10.1007\/s10016-001-0299-x.","journal-title":"Ann Vasc Surg"},{"key":"232_CR30","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.4049\/jimmunol.154.6.2801","volume":"154","author":"LF Brown","year":"1995","unstructured":"Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, et al: Overexpression of vascular permeability factor (VPF\/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol. 1995, 154: 2801-2807.","journal-title":"J Immunol"},{"key":"232_CR31","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.4049\/jimmunol.174.12.7665","volume":"174","author":"J Cao","year":"2005","unstructured":"Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, et al: Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol. 2005, 174: 7665-7675.","journal-title":"J Immunol"},{"key":"232_CR32","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","volume":"171","author":"K Kandere-Grzybowska","year":"2003","unstructured":"Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W, et al: IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol. 2003, 171: 4830-4836.","journal-title":"J Immunol"},{"key":"232_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","volume":"217","author":"TC Theoharides","year":"2007","unstructured":"Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D: Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007, 217: 65-78. 10.1111\/j.1600-065X.2007.00519.x.","journal-title":"Immunol Rev"},{"key":"232_CR34","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1517\/14656560903107789","volume":"10","author":"TC Theoharides","year":"2009","unstructured":"Theoharides TC, Kempuraj D, Redwood L: Autism: an emerging 'neuroimmune disorder' in search of therapy. Exp Opinion on Pharmacotherapy. 2009, 10: 2127-2143. 10.1517\/14656560903107789.","journal-title":"Exp Opinion on Pharmacotherapy"},{"key":"232_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1289\/ehp.7712","volume":"113","author":"TM Burbacher","year":"2005","unstructured":"Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T: Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect. 2005, 113: 1015-1021.","journal-title":"Environ Health Perspect"},{"key":"232_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0006-8993(00)03026-2","volume":"888","author":"P Esposito","year":"2001","unstructured":"Esposito P, Gheorghe D, Kandere K, Pang X, Conally R, Jacobson S, et al: Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001, 888: 117-127. 10.1016\/S0006-8993(00)03026-2.","journal-title":"Brain Res"},{"key":"232_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1124\/jpet.102.038497","volume":"303","author":"P Esposito","year":"2002","unstructured":"Esposito P, Chandler N, Kandere-Grzybowska K, Basu S, Jacobson S, Connolly R, et al: Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther. 2002, 303: 1061-1066. 10.1124\/jpet.102.038497.","journal-title":"J Pharmacol Exp Ther"},{"key":"232_CR38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1096\/fasebj.7.15.8262335","volume":"7","author":"AD Rossi","year":"1993","unstructured":"Rossi AD, Larsson O, Manzo L, Orrenius S, Vahter M, Berggren PO, et al: Modifications of Ca2+ signaling by inorganic mercury in PC12 cells. FASEB J. 1993, 7: 1507-1514.","journal-title":"FASEB J"},{"key":"232_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-3623(98)00258-4","volume":"33","author":"JG Elferink","year":"1999","unstructured":"Elferink JG: Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function-modulating agent. Gen Pharmacol. 1999, 33: 1-6. 10.1016\/S0306-3623(98)00258-4.","journal-title":"Gen Pharmacol"},{"key":"232_CR40","first-page":"268","volume":"10","author":"PM Kidd","year":"2005","unstructured":"Kidd PM: Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005, 10: 268-293.","journal-title":"Altern Med Rev"},{"key":"232_CR41","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1126\/science.1085941","volume":"301","author":"HH Harris","year":"2003","unstructured":"Harris HH, Pickering IJ, George GN: The chemical form of mercury in fish. Science. 2003, 301: 1203-10.1126\/science.1085941.","journal-title":"Science"},{"key":"232_CR42","volume-title":"Proc Society for Neuroscience, Washington DC","author":"AM Persico","year":"2008","unstructured":"Persico AM, Sacco R, Curatolo P, Manzi B, Lenti C, Saccani M, et al: Isolation of principal components in autistic disorder symptomatology and their association with biological endophenotypes. Proc Society for Neuroscience, Washington DC. 2008, Abstract #446.20"},{"key":"232_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2009.09.015","volume":"1-2","author":"ES Magalhaes","year":"2009","unstructured":"Magalhaes ES, Pinto-Mariz F, Bastos-Pinto S, Pontes AT, Prado EA, Deazevedo LC: Immune allergic response in Asperger syndrome. J Neuroimmunol. 2009, 1-2: 108-112. 10.1016\/j.jneuroim.2009.09.015.","journal-title":"J Neuroimmunol"},{"key":"232_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archpedi.160.8.825","volume":"160","author":"JG Gurney","year":"2006","unstructured":"Gurney JG, McPheeters ML, Davis MM: Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health. Arch Pediatr Adolesc Med. 2006, 160: 825-830. 10.1001\/archpedi.160.8.825.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"232_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-5-52","volume":"5","author":"H Jyonouchi","year":"2008","unstructured":"Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008, 5: 52-10.1186\/1742-2094-5-52.","journal-title":"J Neuroinflammation"},{"key":"232_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejpn.2007.12.008","volume":"12","author":"B Bakkaloglu","year":"2008","unstructured":"Bakkaloglu B, Anlar B, Anlar FY, Oktem F, Pehlivanturk B, Unal F, et al: Atopic features in early childhood autism. Eur J Paediatr Neurol. 2008, 12: 476-479. 10.1016\/j.ejpn.2007.12.008.","journal-title":"Eur J Paediatr Neurol"},{"key":"232_CR47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/039463200902200401","volume":"22","author":"TC Theoharides","year":"2009","unstructured":"Theoharides TC: Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol. 2009, 22: 859-865.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"232_CR48","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1542\/peds.2009-1522","volume":"5","author":"MD Kogan","year":"2009","unstructured":"Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, et al: Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009, 5: 1395-1403. 10.1542\/peds.2009-1522.","journal-title":"Pediatrics"},{"key":"232_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.iac.2006.05.005","volume":"26","author":"M Castells","year":"2006","unstructured":"Castells M: Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006, 26: 465-485. 10.1016\/j.iac.2006.05.005.","journal-title":"Immunol Allergy Clin North Am"},{"key":"232_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11882-006-0061-0","volume":"6","author":"C Akin","year":"2006","unstructured":"Akin C, Valent P, Escribano L: Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Curr Allergy Asthma Rep. 2006, 6: 282-288. 10.1007\/s11882-006-0061-0.","journal-title":"Curr Allergy Asthma Rep"},{"key":"232_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.healthplace.2004.11.005","volume":"12","author":"RF Palmer","year":"2006","unstructured":"Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C: Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place. 2006, 12: 203-209. 10.1016\/j.healthplace.2004.11.005.","journal-title":"Health Place"},{"key":"232_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2008.08.021","volume":"280","author":"DA Geier","year":"2008","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, et al: Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci. 2008, 280: 101-108. 10.1016\/j.jns.2008.08.021.","journal-title":"J Neurol Sci"},{"key":"232_CR53","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1080\/15287390701457712","volume":"70","author":"DA Geier","year":"2007","unstructured":"Geier DA, Geier MR: A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A. 2007, 70: 1723-1730. 10.1080\/15287390701457712.","journal-title":"J Toxicol Environ Health A"},{"key":"232_CR54","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1080\/15287390601172080","volume":"70","author":"JB Adams","year":"2007","unstructured":"Adams JB, Romdalvik J, Ramanujam VM, Legator MS: Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A. 2007, 70: 1046-1051. 10.1080\/15287390601172080.","journal-title":"J Toxicol Environ Health A"},{"key":"232_CR55","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/0883073807307111","volume":"22","author":"MC Desoto","year":"2007","unstructured":"Desoto MC, Hitlan RT: Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol. 2007, 22: 1308-1311. 10.1177\/0883073807307111.","journal-title":"J Child Neurol"},{"key":"232_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuro.2007.09.010","volume":"29","author":"R Deth","year":"2008","unstructured":"Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M: How environmental and genetic factors combine to cause autism: A redox\/methylation hypothesis. NeuroToxicol. 2008, 29: 190-201. 10.1016\/j.neuro.2007.09.010.","journal-title":"NeuroToxicol"},{"key":"232_CR57","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"E Fombonne","year":"2009","unstructured":"Fombonne E: Epidemiology of pervasive developmental disorders. Pediatr Res. 2009, 65: 591-598. 10.1203\/PDR.0b013e31819e7203.","journal-title":"Pediatr Res"},{"key":"232_CR58","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1542\/peds.2007-2361","volume":"120","author":"CP Johnson","year":"2007","unstructured":"Johnson CP, Myers SM: Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007, 120: 1183-1215. 10.1542\/peds.2007-2361.","journal-title":"Pediatrics"},{"key":"232_CR59","volume-title":"Brain, Behavior, Immunity","author":"TC Theoharides","year":"2010","unstructured":"Theoharides TC, Angelidou A, Alysandratos K-A: Neonatal mast cell activation and autism. Brain, Behavior, Immunity. 2010."},{"key":"232_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tips.2008.06.002","volume":"29","author":"TC Theoharides","year":"2008","unstructured":"Theoharides TC, Doyle R, Francis K, Conti P, Kalogeromitros D: Novel therapeutic targets for autism. Trends Pharmacol Sci. 2008, 29: 375-382. 10.1016\/j.tips.2008.06.002.","journal-title":"Trends Pharmacol Sci"},{"key":"232_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.1205707","volume":"80","author":"P Ashwood","year":"2006","unstructured":"Ashwood P, Wills S, Water Van de J: The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006, 80: 1-15. 10.1189\/jlb.1205707.","journal-title":"J Leukoc Biol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-7-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T19:39:43Z","timestamp":1685475583000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-7-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-7-20","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]},"assertion":[{"value":"3 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}